Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oncodisc was a digital health company focused on advancing cancer care through intelligent implantable devices and remote patient monitoring technology. It developed a platform combining an intelligent implantable vascular access port with biologic sensors and a remote digital healthcare platform designed to monitor patient physiology for early detection of illness or treatment-related complications in cancer patients. The core technology featured biologic sensors with wireless communication capability integrated into a vascular access port, designed to deliver pharmaceutical therapy while continuously monitoring patient physiology for early detection of treatment-related complications. The company focused on reducing risks associated with cancer treatment through remote patient monitoring and physiologic data collection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oncodisc.